Comparison between Evoq Remedies IPO and Krishna Defence IPO.
Evoq Remedies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Krishna Defence IPO is a SME Bookbuilding proposed to list at NSE SME.
| Evoq Remedies IPO | Krishna Defence IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Evoq Remedies IPO is up to ₹9.23 Cr whereas the issue size of the Krishna Defence IPO is up to ₹11.28 Cr. The final issue price of Evoq Remedies IPO is ₹27.00 per share and of Krishna Defence IPO is ₹39.00 per share.
| Evoq Remedies IPO | Krishna Defence IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹37.00 per share | |
| Issue Price (Upper) | ₹39.00 per share | |
| Issue Price (Final) | ₹27.00 per share | ₹39.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 3000 shares |
| Fresh Issue Size | 34,20,000 shares | 28,92,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.23 Cr | up to ₹11.28 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 34,20,000 shares | 28,92,000 shares |
| Issue Size Total (Amount) | up to ₹9.23 Cr | up to ₹11.28 Cr |
Evoq Remedies IPO opens on Mar 17, 2022, while Krishna Defence IPO opens on Mar 25, 2022. The closing date of Evoq Remedies IPO and Krishna Defence IPO is Mar 22, 2022, and Mar 29, 2022, respectively.
| Evoq Remedies IPO | Krishna Defence IPO | |
|---|---|---|
| Anchor Bid Date | Mar 24, 2022 | |
| Issue Open | Mar 17, 2022 | Mar 25, 2022 |
| Issue Close | Mar 22, 2022 | Mar 29, 2022 |
| Basis Of Allotment (Tentative) | Mar 25, 2022 | Apr 01, 2022 |
| Initiation of Refunds (Tentative) | Mar 28, 2022 | Apr 04, 2022 |
| Credit of Share (Tentative) | Mar 29, 2022 | Apr 05, 2022 |
| Listing date (Tentative) | Mar 30, 2022 | Apr 06, 2022 |
| Anchor Lockin End date 1 | May 01, 2022 | |
| Anchor Lockin End date 2 | Jun 30, 2022 |
Evoq Remedies IPO P/E ratio is 33.75, as compared to Krishna Defence IPO P/E ratio of 18.
| Evoq Remedies IPO | Krishna Defence IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | 73.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 33.75 | 18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹36.72 Cr. | ₹44.65 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Evoq Remedies IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Krishna Defence IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Evoq Remedies IPO and 5,79,000 shares in Krishna Defence IPO.
| Evoq Remedies IPO | Krishna Defence IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,64,000 shares | |
| Market Maker Reserveration | 1,80,000 shares | 1,56,000 shares |
| QIB | 5,79,000 shares | |
| NII | 17,10,000 shares | 4,35,000 shares |
| RII | 17,10,000 shares | 10,14,000 shares |
| Employee | ||
| Others | ||
| Total | 34,20,000 shares | 28,92,000 shares |
Evoq Remedies IPO subscribed 1.67x in total, whereas Krishna Defence IPO subscribed 74.84x.
| Evoq Remedies IPO | Krishna Defence IPO | |
|---|---|---|
| QIB (times) | 8.84x | |
| NII (times) | 0.30x | 159.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.03x | 132.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.67x | 74.84x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
